Jushi (OTCMKTS:JUSHF – Get Free Report) is one of 53 public companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its peers? We will compare Jushi to similar companies based on the strength of its profitability, risk, institutional ownership, earnings, dividends, valuation and analyst recommendations.
Risk & Volatility
Jushi has a beta of -0.16, meaning that its share price is 116% less volatile than the S&P 500. Comparatively, Jushi’s peers have a beta of 1.40, meaning that their average share price is 40% more volatile than the S&P 500.
Earnings & Valuation
This table compares Jushi and its peers top-line revenue, earnings per share and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Jushi | $269.45 million | -$65.10 million | -1.93 |
Jushi Competitors | $323.20 million | -$162.62 million | -10.00 |
Institutional and Insider Ownership
21.7% of Jushi shares are held by institutional investors. Comparatively, 14.3% of shares of all “Medicinals & botanicals” companies are held by institutional investors. 21.0% of Jushi shares are held by insiders. Comparatively, 21.5% of shares of all “Medicinals & botanicals” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and price targets for Jushi and its peers, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Jushi | 0 | 2 | 0 | 0 | 2.00 |
Jushi Competitors | 203 | 531 | 843 | 66 | 2.47 |
As a group, “Medicinals & botanicals” companies have a potential upside of 70.25%. Given Jushi’s peers stronger consensus rating and higher probable upside, analysts plainly believe Jushi has less favorable growth aspects than its peers.
Profitability
This table compares Jushi and its peers’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Jushi | -24.16% | -320.66% | -10.31% |
Jushi Competitors | -45.95% | -62.18% | -9.03% |
Summary
Jushi peers beat Jushi on 9 of the 13 factors compared.
About Jushi
Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.
Receive News & Ratings for Jushi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jushi and related companies with MarketBeat.com's FREE daily email newsletter.